PT Pyridam Farma Tbk (PYFA) Stock Statistics & Valuation Metrics
Total Valuation
PT Pyridam Farma Tbk has a market cap or net worth of IDR 1.33T. The enterprise value is IDR 7.92T.
- Market Cap
- IDR 1.33T
- Enterprise Value
- IDR 7.92T
Share Statistics
PT Pyridam Farma Tbk has 11,236,752,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 11,236,752,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
PT Pyridam Farma Tbk’s return on equity (ROE) is -0.50 and return on invested capital (ROIC) is -1.93%.
- Return on Equity (ROE)
- -0.50
- Return on Assets (ROA)
- -0.06
- Return on Invested Capital (ROIC)
- -1.93%
- Return on Capital Employed (ROCE)
- -0.03
- Revenue Per Employee
- 1.18B
- Profits Per Employee
- -162.18M
- Employee Count
- 2,341
- Asset Turnover
- 0.41
- Inventory Turnover
- 4.70
Valuation Ratios
The current PE Ratio of PT Pyridam Farma Tbk is -3.85. PT Pyridam Farma Tbk’s PEG ratio is -0.23.
- PE Ratio
- -3.85
- PS Ratio
- 0.44
- PB Ratio
- 1.94
- Price to FCF
- -2.35
- Price to Operating Cash Flow
- -3.11
- PEG Ratio
- -0.23
Income Statement
In the last 12 months, PT Pyridam Farma Tbk had revenue of 2.76T and earned -379.67B in profits. Earnings per share was -33.79.
- Revenue
- 2.76T
- Gross Profit
- 485.54B
- Operating Income
- -164.10B
- Pretax Income
- -530.87B
- Net Income
- -379.67B
- EBITDA
- 128.59B
- Earnings Per Share (EPS)
- -33.79
Cash Flow
In the last 12 months, operating cash flow was -427.01B and capital expenditures -138.06B, giving a free cash flow of -565.07B billion.
- Operating Cash Flow
- -427.01B
- Free Cash Flow
- -565.07B
- Free Cash Flow per Share
- -50.29
Dividends & Yields
PT Pyridam Farma Tbk pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -42.62%
- Earnings Yield
- -26.00%
Stock Price Statistics
- Beta
- 1.95
- 52-Week Price Change
- -76.11%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 26.12
- Average Volume (3m)
- 22.71M
Important Dates
PT Pyridam Farma Tbk upcoming earnings date is Apr 15, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 02, 2026
- Next Earnings Date
- Apr 15, 2027
- Ex-Dividend Date
- ―
Financial Position
PT Pyridam Farma Tbk as a current ratio of 1.24, with Debt / Equity ratio of 631.22%
- Current Ratio
- 1.24
- Quick Ratio
- 0.82
- Debt to Market Cap
- 0.68
- Net Debt to EBITDA
- 36.86
- Interest Coverage Ratio
- -0.50
Taxes
In the past 12 months, PT Pyridam Farma Tbk has paid -151.20B in taxes.
- Income Tax
- -151.20B
- Effective Tax Rate
- 0.28
Enterprise Valuation
PT Pyridam Farma Tbk EV to EBITDA ratio is 39.02, with an EV/FCF ratio of -11.65.
- EV to Sales
- 2.20
- EV to EBITDA
- 39.02
- EV to Free Cash Flow
- -11.65
- EV to Operating Cash Flow
- -15.42
Balance Sheet
PT Pyridam Farma Tbk has IDR 127.11B in cash and marketable securities with IDR 5.39T in debt, giving a net cash position of -IDR 5.26T billion.
- Cash & Marketable Securities
- IDR 127.11B
- Total Debt
- IDR 5.39T
- Net Cash
- -IDR 5.26T
- Net Cash Per Share
- -IDR 468.02
- Tangible Book Value Per Share
- -IDR 189.37
Margins
Gross margin is 18.33%, with operating margin of -3.84%, and net profit margin of -11.52%.
- Gross Margin
- 18.33%
- Operating Margin
- -3.84%
- Pretax Margin
- -16.29%
- Net Profit Margin
- -11.52%
- EBITDA Margin
- 5.64%
- EBIT Margin
- -5.04%
Analyst Forecast
The average price target for PT Pyridam Farma Tbk is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 10.49%
- EPS Growth Forecast
- 26.98%
